Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 2911-2920 Newer>

The Motley Fool May 17, 2006 S.J. Caplan	A Shapelier Knee Zimmer gains clearance for a female knee-replacement device. The company's new device should certainly be able to boost revenue by being first to exploit the female marketing angle. Investors, take note.
The Motley Fool May 16, 2006 Stephen D. Simpson	The FDA Tries to Put Neurocrine to Sleep A surprisingly worded rejection sends two stocks skidding. But setbacks aren't always terminal. While it won't be easy, Neurocrine Biosciences and DOV Pharmaceuticals investors may just want to hang on.
The Motley Fool May 15, 2006 Brian Gorman	AstraZeneca's Peer-Pressure Purchase The drug company seems to be paying a lot for Cambridge Antibody. Perhaps AstraZeneca didn't want to be left behind as its rivals bought up biotech technology -- but in its haste, it may be paying a steep price for what it's getting. Investors, take note.
The Motley Fool May 12, 2006 Rich Duprey	Cutera Continues to Burn The aesthetic laser maker is at risk of losing a patent lawsuit against a competitor. Investors, patents by themselves should not be considered a sufficient competitive moat to induce investment in a company.
Insurance & Technology May 3, 2006 Maria Woehr	Building a Foundation Blue Cross Blue Shield of Michigan is helping to lay out a blueprint for the Michigan Health Information Network, which is charting a plan for establishing a statewide electronic health records system.
Bio-IT World May 2006 Kevin Davies	Decoding the Genetics of Common Disease Icelandic biopharma deCODE Genetics' Kari Stefansson says his company's search for genes underlying common diseases is not only pushing promising new drug candidates into the clinic but also revealing new insights into the very basis of common disease.
Bio-IT World May 2006 Kevin Davies	Personalized Medicine's Rosy Picture GlaxoSmithKline's head of genetics research, Allen Roses, says that pharmacogenetics is having a profound impact on the stratifying of patients, the minimization of adverse events, and the expedited passage of drug candidates through clinical trials.
Bio-IT World May 2006 Kevin Davies	Interpreting Genes and Genomes From microarrays to sequencing technology, molecular diagnostics to the interactome, this year's Bio-IT World Conference showcased exciting advances in genome technology applications, in which software analysis and data management play critical roles.
Bio-IT World May 2006 Mark D. Uehling	Clinical Speakers Enjoy Industry Acceptance For the first time at the Bio-IT World Conference, the clinical speakers did not wring their hands about whether their tools would be accepted by the industry. This year, it was a question of how quickly technology would be used to expedite trials and raise the quality of the data therein.
Bio-IT World May 2006 Salvatore Salamone	Get Serious About Information Mining Life science companies have long faced the problem of information silos. In a session on text, data mining, and the Web at last month's Bio-IT World Expo, industry experts talked about some of the challenges and solutions that might help break down silos.
<Older 2911-2920 Newer> Return to current articles.